# Kraig Biocraft Laboratories, Inc.: Form 8-K/A, filed Apr 12, 2022

- Company: [Kraig Biocraft Laboratories, Inc.](/companies/kblb.md) (CIK 1413119)
- Form: 8-K/A
- Filed: 2022-04-12
- Accepted by EDGAR: Apr 12, 2022, 16:30 ET
- Period: 2022-01-20
- Accession: 0001493152-22-009703
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1413119/000149315222009703/form8-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1413119/000149315222009703/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1413119/000149315222009703/form8-ka.htm

Filed Apr 12, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-009703. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.